- Home
- PRCH vs ALDX Comparison
PRCH vs ALDX Comparison
Compare PRCH & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRCH
- ALDX
- Stock Information
- Founded
- PRCH 2012
- ALDX 2004
- Country
- PRCH United States
- ALDX United States
- Employees
- PRCH N/A
- ALDX N/A
- Industry
- PRCH Computer Software: Prepackaged Software
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- PRCH Technology
- ALDX Health Care
- Exchange
- PRCH Nasdaq
- ALDX Nasdaq
- Market Cap
- PRCH 370.5M
- ALDX 319.4M
- IPO Year
- PRCH N/A
- ALDX 2014
- Fundamental
- Price
- PRCH $5.33
- ALDX $5.03
- Analyst Decision
- PRCH Buy
- ALDX Strong Buy
- Analyst Count
- PRCH 8
- ALDX 2
- Target Price
- PRCH $5.34
- ALDX $10.00
- AVG Volume (30 Days)
- PRCH 3.0M
- ALDX 430.5K
- Earning Date
- PRCH 11-07-2024
- ALDX 11-07-2024
- Dividend Yield
- PRCH N/A
- ALDX N/A
- EPS Growth
- PRCH N/A
- ALDX N/A
- EPS
- PRCH N/A
- ALDX N/A
- Revenue
- PRCH $452,099,000.00
- ALDX N/A
- Revenue This Year
- PRCH $6.30
- ALDX N/A
- Revenue Next Year
- PRCH N/A
- ALDX N/A
- P/E Ratio
- PRCH N/A
- ALDX N/A
- Revenue Growth
- PRCH 19.04
- ALDX N/A
- 52 Week Low
- PRCH $1.05
- ALDX $2.71
- 52 Week High
- PRCH $6.04
- ALDX $6.55
- Technical
- Relative Strength Index (RSI)
- PRCH 64.05
- ALDX 56.01
- Support Level
- PRCH $5.13
- ALDX $4.82
- Resistance Level
- PRCH $6.04
- ALDX $5.42
- Average True Range (ATR)
- PRCH 0.59
- ALDX 0.29
- MACD
- PRCH -0.00
- ALDX 0.05
- Stochastic Oscillator
- PRCH 73.76
- ALDX 80.52
About PRCH Porch Group Inc.
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.